Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database

OBJECTIVE: The haematopoietic cytopenia (HC) of the cyclin-dependent kinase (CDK)4/6 inhibitors was evaluated using the Food and Drug Administration Adverse Event Reporting System (FAERS). METHOD: Data from 1 January 2015 to 31 December 2021 has been retrieved from the FAERS database. Disproportiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiayang, Yan, Cilin, Tian, Le, Cui, Xiangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Orginal Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793014/
https://www.ncbi.nlm.nih.gov/pubmed/36565299
http://dx.doi.org/10.1177/03946320221145520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793014/
https://www.ncbi.nlm.nih.gov/pubmed/36565299
http://dx.doi.org/10.1177/03946320221145520

Ejemplares similares